89 related articles for article (PubMed ID: 14740552)
41. An interleukin 1 receptor antagonist blocks the IL-1-induced IL-6 paracrine production through a prostaglandin E2-related mechanism in multiple myeloma.
Lu ZY; Bataille R; Poubelle P; Rapp MJ; Harousseau JL; Klein B
Stem Cells; 1995 Aug; 13 Suppl 2():28-34. PubMed ID: 8520508
[TBL] [Abstract][Full Text] [Related]
42. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra).
Conti P; Panara MR; Fridas S; Barbacane RC; Grilli A; Placido FC; Reale M; Fiore S
Cell Immunol; 1993 Apr; 147(2):446-57. PubMed ID: 8384086
[TBL] [Abstract][Full Text] [Related]
44. The effects of synovial fluid macrophages and interleukin-1 on hyaluronic acid synthesis by normal synovial fibroblasts.
Pulkki K
Rheumatol Int; 1986; 6(3):121-5. PubMed ID: 3489274
[TBL] [Abstract][Full Text] [Related]
45. [Effect of dexamethasone on expression of intercellular adhesion molecule-1 in orbital fibroblasts from thyroid associated ophthalmopathy].
He WM; Luo QL; Zeng JH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):113-5. PubMed ID: 17294742
[TBL] [Abstract][Full Text] [Related]
46. Inhibitory effects of Triptolide on interferon-gamma-induced human leucocyte antigen-DR, intercellular adhesion molecule-1, CD40 expression on retro-ocular fibroblasts derived from patients with Graves' ophthalmopathy.
Yan SX; Wang Y
Clin Exp Ophthalmol; 2006 Apr; 34(3):265-71. PubMed ID: 16671908
[TBL] [Abstract][Full Text] [Related]
47. Altered ganglioside expression modulates the pathogenic mechanism of thyroid-associated ophthalmopathy by increase in hyaluronic acid.
Kook KH; Choi YH; Kim YR; Park SJ; Jou I; Kim SJ; Lee SY
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):264-73. PubMed ID: 20811057
[TBL] [Abstract][Full Text] [Related]
48. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor.
Burger D; Chicheportiche R; Giri JG; Dayer JM
J Clin Invest; 1995 Jul; 96(1):38-41. PubMed ID: 7615809
[TBL] [Abstract][Full Text] [Related]
49. Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts.
Lonnemann G; Shapiro L; Engler-Blum G; Müller GA; Koch KM; Dinarello CA
Kidney Int; 1995 Mar; 47(3):837-44. PubMed ID: 7752582
[TBL] [Abstract][Full Text] [Related]
50. Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.
Molnar C; Garcia-Trevijano ER; Ludwiczek O; Talabot D; Kaser A; Mato JM; Fritsche G; Weiss G; Gabay C; Avila MA; Tilg H
Eur Cytokine Netw; 2004; 15(4):303-11. PubMed ID: 15627638
[TBL] [Abstract][Full Text] [Related]
51. Effect of interleukin-1 receptor antagonist on vascular smooth muscle cell proliferation.
Porreca E; Di Febbo C; Barbacane RC; Panara MR; Cuccurullo F; Conti P
Atherosclerosis; 1993 Feb; 99(1):71-8. PubMed ID: 8461062
[TBL] [Abstract][Full Text] [Related]
52. Expression of an insulin/interleukin-1 receptor antagonist hybrid gene in insulin-producing cell lines (HIT-T15 and NIT-1) confers resistance against interleukin-1-induced nitric oxide production.
Welsh N; Bendtzen K; Welsh M
J Clin Invest; 1995 Apr; 95(4):1717-22. PubMed ID: 7706480
[TBL] [Abstract][Full Text] [Related]
53. Intracellular IL-1 receptor antagonist is elevated in human dermal fibroblasts that overexpress intracellular precursor IL-1 alpha.
Higgins GC; Wu Y; Postlethwaite AE
J Immunol; 1999 Oct; 163(7):3969-75. PubMed ID: 10490999
[TBL] [Abstract][Full Text] [Related]
54. Interleukin 13 suppresses cytokine production and stimulates the production of 15-HETE in PBMC. A comparison between IL-4 and IL-13.
Deleuran B; Iversen L; Deleuran M; Yssel H; Kragballe K; Stengaard-Pedersen K; Thestrup-Pedersen K
Cytokine; 1995 May; 7(4):319-24. PubMed ID: 8589261
[TBL] [Abstract][Full Text] [Related]
55. Modulation of cell proliferation and cytokine production in AML by recombinant interleukin-1 receptor antagonist.
Rambaldi A; Torcia M; Dinarello CA; Barbui T; Cozzolino F
Leukemia; 1993 Aug; 7 Suppl 2():S10-2. PubMed ID: 8361209
[TBL] [Abstract][Full Text] [Related]
56. Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.
McKenzie RC; Oran A; Dinarello CA; Sauder DN
Anticancer Res; 1996; 16(1):437-41. PubMed ID: 8615650
[TBL] [Abstract][Full Text] [Related]
57. Growth modulation of human prostatic cancer cells by interleukin-1 and interleukin-1 receptor antagonist.
Hsieh TC; Chiao JW
Cancer Lett; 1995 Aug; 95(1-2):119-23. PubMed ID: 7656219
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy.
Jyonouchi SC; Valyasevi RW; Harteneck DA; Dutton CM; Bahn RS
Thyroid; 2001 Oct; 11(10):929-34. PubMed ID: 11716039
[TBL] [Abstract][Full Text] [Related]
59. Smoking and thyroid-associated ophthalmopathy: A novel explanation of the biological link.
Cawood TJ; Moriarty P; O'Farrelly C; O'Shea D
J Clin Endocrinol Metab; 2007 Jan; 92(1):59-64. PubMed ID: 17047020
[TBL] [Abstract][Full Text] [Related]
60. T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathy.
Han R; Smith TJ
Endocrinology; 2006 Jan; 147(1):13-9. PubMed ID: 16210363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
